Selective Thrombophilia Screening in Young Patients with Retinal Artery Occlusion

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Ophthalmologica

• Publication date

  2016-05-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000446028PMID 27173060
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus

  2015cited by this paper
• Thrombophilia in Patients with Retinal Vein Occlusion: A Retrospective Analysis

  2014cited by this paper
• Management of Retinal Vein Occlusion – Consensus Document

  2011cited by this paper
• The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors.

  2010cited by this paper
• Ocular artery thrombosis as an initial presentation of a prothrombin G20210A mutation.

  2010cited by this paper
• Coagulation disorders and the risk of retinal vein occlusion

  2009cited by this paper
• Selective thrombophilia screening of patients with nonarteritic anterior ischemic optic neuropathy

  2009cited by this paper
• Retinal artery occlusion: associated systemic and ophthalmic abnormalities.

  2009cited by this paper
• Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion.

  2008cited by this paper
• Thrombophilic screening in retinal artery occlusion patients

  2008cited by this paper
• Protein S deficiency manifesting simultaneously as central retinal artery occlusion, oculomotor nerve palsy, and systemic arterial occlusive diseases

  2007cited by this paper
• Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion

  2007cited by this paper
• Low density lipoprotein triglycerides and lipoprotein(a) are risk factors for retinal vascular occlusion.

  2007cited by this paper
• Inherited thrombophilia in arterial disease: a selective review.

  2007cited by this paper
• Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1

  2006cited by this paper
• Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis

  2005cited by this paper
• Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage

  2005cited by this paper
• Screening for thrombophilia in high‐risk situations: a meta‐analysis and cost‐effectiveness analysis

  2005cited by this paper
• von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis.

  2005cited by this paper
• Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion.

  2004cited by this paper
• [Occlusion of the retinal artery].

  2003cited by this paper
• Arterielle retinale Verschlüsse

  2003cited by this paper
• High prevalence of resistance to APC in young patients with retinal vein occlusion

  2002cited by this paper
• Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source

  2001cited by this paper
• The Incidence of Central Retinal Artery Occlusion in the District of Split, Croatia

  2001cited by this paper
• No Excess of Factor V:Q506 Genotype but High Prevalence of Anticardiolipin Antibodies without Antiendothelial Cell Antibodies in Retinal Vein Occlusion in Young Patients

  2001cited by this paper
• Retinal vascular occlusion and deficiencies in the protein C pathway.

  2000cited by this paper
• Central retinal artery occlusion in a patient homozygous for factor V Leiden.

  2000cited by this paper
• Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.

  2000cited by this paper
• Retinal vascular occlusion and deficiencies in the protein C pathway.

  1999cited by this paper
• Visual Outcome after Treatment with Low-Dose Recombinant Tissue Plasminogen Activator or Hemodilution in Ischemic Central Retinal Vein Occlusion

  1999cited by this paper
• Plasma lipoprotein(a) levels are high in patients with central retinal artery occlusion.

  1998cited by this paper
• Arterial vascular occlusion associated with factor V Leiden gene mutation.

  1998cited by this paper
• Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: Implications for increased vascular risk

  1998cited by this paper
• The Leiden Thrombophilia Study (LETS)

  1997cited by this paper
• Retinal arterial occlusions in young adults.

  1996cited by this paper
• Retinal arterial occlusions in young adults.

  1995cited by this paper
• Plasma concentration of lipoprotein(a) and the risk of future stroke.

  1995cited by this paper
• Protein C, protein S, and antithrombin III in acute ocular occlusive diseases.

  1995cited by this paper
• Myocardial infarction associated with homozygous resistance to activated protein C.

  1994cited by this paper
• A prospective study of lipoprotein(a) and the risk of myocardial infarction.

  1993cited by this paper
• Mortality and causes of death in Dutch haemophiliacs, 1973–86

  1989cited by this paper

• Der retinale Arterienverschluss

  2026cites this paper
• Central Retinal Artery Occlusion in a 6-Year-Old Child with an Acute Chickenpox Infection: A Case Report

  2025cites this paper
• High prevalence of thrombophilic risk factors in patients with central retinal artery occlusion

  2023influential citation
• Internistische Abklärung bei retinalen Gefäßverschlüssen

  2023cites this paper
• Central Retinal Artery Occlusion Secondary to Patent Foramen Ovale: The Unexpected Journey of a Paradoxical Embolus

  2020cites this paper
• Standard Diffusion-weighted MRI for the Diagnosis of Central Retinal Artery Occlusion

  2020cites this paper
• Assessing the risk of stroke development following retinal artery occlusion.

  2020cites this paper